- Home
- UAMY vs BMEZ Comparison
UAMY vs BMEZ Comparison
Compare UAMY & BMEZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UAMY | BMEZ |
|---|---|---|
| Founded | 1968 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 829.0M | 923.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | UAMY | BMEZ |
|---|---|---|
| Price | $6.00 | $15.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.69 | N/A |
| AVG Volume (30 Days) | ★ 8.5M | 391.3K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.71% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | ★ $31,857,819.00 | N/A |
| Revenue This Year | $159.13 | N/A |
| Revenue Next Year | $228.42 | N/A |
| P/E Ratio | ★ N/A | $30.17 |
| Revenue Growth | ★ 177.97 | N/A |
| 52 Week Low | $1.21 | $12.93 |
| 52 Week High | $19.71 | $16.95 |
Technical Indicators
Market Signals| Indicator | UAMY | BMEZ |
|---|---|---|
| Relative Strength Index (RSI) | 42.94 | 54.21 |
| Support Level | $5.16 | $15.10 |
| Resistance Level | $6.95 | $15.67 |
| Average True Range (ATR) | 0.49 | 0.24 |
| MACD | 0.13 | -0.01 |
| Stochastic Oscillator | 46.37 | 54.60 |
Price Performance
Historical ComparisonAbout UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.
About BMEZ BlackRock Health Sciences Term Trust of Beneficial Interest
BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.